Bumper Offer - Urjas oil Just @ Rs. 1
Pregaba 75 Capsule is a prescription drug, available for use as Capsule. It is typically used for the treatment of Neuropathic Pain, Epilepsy, Anxiety. The alternative uses of Pregaba 75 Capsule have also been explained below.
The optimal dosage of Pregaba 75 Capsule is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Pregaba 75 Capsule have been listed ahead. Normally, these side effects of Pregaba 75 Capsule are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Pregaba 75 Capsule is Moderate for pregnant women and Severe for women who are breastfeeding. In addition, Pregaba 75 Capsule's effects on the liver, heart and kidney are discussed below in the Pregaba 75 Capsule related warnings section.
Other conditions have been mentioned below in the Pregaba 75 Capsule contraindications section.
Besides this, Pregaba 75 Capsule may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Pregaba 75 Capsule, it is important to know that it is not safe while driving, and is not habit-forming.
Pregaba 75 Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Pregaba 75 Capsule is used -
Moderate
Mild
Is the use of Pregaba 75 Capsule safe for pregnant women?
Pregaba may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Pregaba again without your doctor's advice.
Is the use of Pregaba 75 Capsule safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Pregaba. So it is adviced to consult the doctor before using it.
What is the effect of Pregaba 75 Capsule on the Kidneys?
Pregaba rarely harms the kidneys.
What is the effect of Pregaba 75 Capsule on the Liver?
Pregaba is completely safe for the liver.
What is the effect of Pregaba 75 Capsule on the Heart?
There are no any side effects of Pregaba for the heart.
Pregaba 75 Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Pregaba 75 Capsule unless your doctor advises you to do so -
Is this Pregaba 75 Capsule habit forming or addictive?
No, you will not get addicted to Pregaba 75 Capsule.
Is it safe to drive or operate heavy machinery when consuming?
After taking Pregaba 75 Capsule you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Pregaba 75 Capsule should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, taking Pregaba 75 Capsule can treat mental disorders.
Interaction between Food and Pregaba 75 Capsule
Taking Pregaba 75 Capsule with food does not cause any problems.
Interaction between Alcohol and Pregaba 75 Capsule
Taking alcohol with Pregaba 75 Capsule can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420